McDonnell Boehnen Hulbert & Berghoff LLP
Acetanilide sphingosine-1-phosphate receptor antagonists
This disclosure relates to sphingosine-1-phosphate (S1P) receptor antagonists, compositions comprising the S1P receptor antagonists and methods for using and processes for making the S1P receptor antagonists. In particular, this disclosure relates to sphingosine-1-phosphate 1 (S1P1) receptor antagonists, compositions comprising the S1P1 receptor antagonist and methods for using the S1P1 receptor antagonist, such as in the treatment of cancer, and processes for making the S1P1 receptor antagonists.
Exelixis, Inc.
C C C C C C C C C C A C C C C C C C C C C C C C C C C C C C A C C C C A C C C C C C C C C
C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D A61P C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D A61P C07D C07D C07D C07D A61P C07D C07D C07D C07D C07D C07D C07D C07D C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Patrick John M. Henry William Beecroft Joon Won Gary L. James W. Mohamed Abdulkader Robin Tammie
Kearney Nuss Johnson Jeong Lewis Leahy Ibrahim Noguchi